Early research showed nasoduodenal tube delivery of amifostine may help protect the duodenum during radiation for pancreatic cancer. A phase 1/phase 2 clinical trial will begin later this year.

Survival at 90 days reached 73% with fecal transplant delivered via a nasoduodenal tube compared with 40% with standard care alone (P= 0.02), with more than twice as many patients alive at 6 ...

The researchers found that, compared with vancomycin, both nasoduodenal and colorectal FMT resulted in improved quality of life and reduced cost.

There was a significant variation in the routes assessed (including intravenous fluid therapy, peripheral and central line nutrition, feeding jejunostomy, nasojejunal and nasoduodenal tubes) and ...

Furthermore, the amount of feces required and the importance of varying potential routes of infusion (nasoduodenal tube, enema, or colonoscopy) are unknown since the literature reports many ...

Survival at 90 days reached 73% with fecal transplant delivered via a nasoduodenal tube compared with 40% with standard care alone (P=0.02), with more than twice as many patients alive at 6 months ...